{"id":7277,"date":"2024-09-17T12:17:31","date_gmt":"2024-09-17T11:17:31","guid":{"rendered":"https:\/\/touchmedicalmedia.com\/?p=7277"},"modified":"2024-09-17T12:17:31","modified_gmt":"2024-09-17T11:17:31","slug":"touchoncology-and-touchhaematology-new-partnership-with-costem","status":"publish","type":"post","link":"https:\/\/touchmedicalmedia.com\/news\/touchoncology-and-touchhaematology-new-partnership-with-costem\/","title":{"rendered":"touchONCOLOGY and touchHAEMATOLOGY New Partnership with COSTEM"},"content":{"rendered":"

 <\/p>\n

\"\"<\/p>\n

“We are excited to collaborate with COSTEM, aligned by our shared dedication to the oncology and hematology communities, with the goal of facilitating the exchange of knowledge and experiences to advance progress towards improved patient outcomes.” \u00a0<\/i><\/p><\/blockquote>\n

Nicola Cartridge, Head of Content<\/p>\n

COSTEM 2024 promises to be a progressive, compelling and informative congress, where the most compelling and controversial topics facing clinicians in our field are presented in a fascinating and exciting debate forum. COSTEM 2024 will showcase controversy debates including these topics: Acute leukemia, Bi-specific antibodies, CAR T-cell therapy and cellular therapy, Drug conjugated antibodies and Genome editing and gene therapy<\/p>\n

For more information about the congress\u00a0click here<\/a><\/span><\/p>\n

You can also\u00a0get in touch<\/a><\/span>\u00a0to learn how you can benefit from our educational activities and regularly updated content and\u00a0find out more about our medical society partnerships.<\/p>\n","protected":false},"excerpt":{"rendered":"

“We are excited to collaborate with COSTEM, aligned by our shared dedication to the oncology and hematology communities, with the goal of facilitating the exchange of knowledge and experiences to advance progress towards improved patient outcomes.”<\/p>\n","protected":false},"author":101775,"featured_media":7307,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"","_relevanssi_noindex_reason":"","rank_math_lock_modified_date":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-7277","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorised","vocabulary_1-partnerships"],"acf":[],"_links":{"self":[{"href":"https:\/\/touchmedicalmedia.com\/wp-json\/wp\/v2\/posts\/7277"}],"collection":[{"href":"https:\/\/touchmedicalmedia.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/touchmedicalmedia.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/touchmedicalmedia.com\/wp-json\/wp\/v2\/users\/101775"}],"replies":[{"embeddable":true,"href":"https:\/\/touchmedicalmedia.com\/wp-json\/wp\/v2\/comments?post=7277"}],"version-history":[{"count":6,"href":"https:\/\/touchmedicalmedia.com\/wp-json\/wp\/v2\/posts\/7277\/revisions"}],"predecessor-version":[{"id":7317,"href":"https:\/\/touchmedicalmedia.com\/wp-json\/wp\/v2\/posts\/7277\/revisions\/7317"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/touchmedicalmedia.com\/wp-json\/wp\/v2\/media\/7307"}],"wp:attachment":[{"href":"https:\/\/touchmedicalmedia.com\/wp-json\/wp\/v2\/media?parent=7277"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/touchmedicalmedia.com\/wp-json\/wp\/v2\/categories?post=7277"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/touchmedicalmedia.com\/wp-json\/wp\/v2\/tags?post=7277"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}